[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website
Drugs at FDA: FDA Approved Drug Products.  Links to Initial Search Page FAQ  |  Instructions  |  Glossary  |  Contact Us  |  CDER Home 
Start Over (Drugs@FDA Home) Back to Search Results

Overview

Drug Name ZITHROMAX
Active Ingredient(s) • AZITHROMYCIN
Form(s) and
Strength(s) Available
• CAPSULE; ORAL: EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
• FOR SUSPENSION; ORAL: EQ 100MG BASE/5ML; EQ 1GM BASE/PACKET; EQ 200MG BASE/5ML
• INJECTABLE; INJECTION: EQ 500MG BASE/VIAL
• TABLET; ORAL: EQ 250MG BASE; EQ 500MG BASE; EQ 600MG BASE

Details about drugs are organized by FDA Application Number (NDA or ANDA or BLA).

Click on a drug name or application number to view drug details:
    Click on a column header to re-sort the table:

Drug Name
and
FDA Application
Number

Dosage Form/Route

Strength

Marketing Status

Company
ZITHROMAX
(NDA # 050670)
CAPSULE; ORAL  EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**  Discontinued PFIZER
ZITHROMAX
(NDA # 050693)
FOR SUSPENSION; ORAL  EQ 1GM BASE/PACKET  Prescription PFIZER
ZITHROMAX
(NDA # 050710)
FOR SUSPENSION; ORAL  Multiple Strengths  Prescription PFIZER
ZITHROMAX
(NDA # 050711)
TABLET; ORAL  EQ 250MG BASE  Prescription PFIZER
ZITHROMAX
(NDA # 050730)
TABLET; ORAL  EQ 600MG BASE  Prescription PFIZER
ZITHROMAX
(NDA # 050733)
INJECTABLE; INJECTION  EQ 500MG BASE/VIAL  Prescription PFIZER
ZITHROMAX
(NDA # 050784)
TABLET; ORAL  EQ 500MG BASE  Prescription PFIZER

Back to Top | Back to Previous Page | Back to Drugs@FDA Home

FDA/Center for Drug Evaluation and Research
Office of Training and Communications
Division of Information Services
Update Frequency: Daily